Down-regulation of Survivin by Antisense Oligonucleotides Increases Apoptosis, Inhibits Cytokinesis and Anchorage-Independent Growth
Jun Chen(Fourth People's Hospital of Taiyuan), Shi‐Chung Ng(Ligand Pharmaceuticals (United States)), Wei Wu(Huanggang Normal University), Maryla Krajewska(Sanford Burnham Prebys Medical Discovery Institute), Paul E. Kroeger(Abbott (United States)), John C. Reed(University of North Carolina at Chapel Hill), Stephen K. Tahir(Abbott Fund), Kate Welsh(Ionis Pharmaceuticals (United States)), Saul H. Rosenberg(Abbott Fund), Lex M. Cowsert(Ionis Pharmaceuticals (United States)), Frank Bennett(Ionis Pharmaceuticals (United States)), Stanisław Krajewski(Sanford Burnham Prebys Medical Discovery Institute)
Cited by 212
Related Papers
Food, nutrition, physical activity, and the prevention of cancer: a global perspective
|Choice Reviews Online|2008|5.4k
ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets
|Nature Medicine|2013|3k
IAP family proteins---suppressors of apoptosis
|Genes & Development|1999|2.5k
ABT-263: A Potent and Orally Bioavailable Bcl-2 Family Inhibitor
|Cancer Research|2008|2k